Drugmaker Eli Lilly is testing a new experimental drug that could be a game changer in treating high cholesterol, it said. Researchers say the new drug, called VERVE-102, could be administered to ...

A new drug has cured 20% of patients with a chronic, cancer-causing disease — which was previously incurable. A viral ...

Research found that the weight-loss medications may reduce the spread of several obesity-related cancers, including lung, ...

Retatrutide, Eli Lilly’s new experimental drug, helped some participants lose up to 28 percent of their body weight in clinical trials.

Eli Lilly's new experimental weight loss drug retatrutide yielded up to 28% weight loss, which is greater than that of ...

Starting in July, Medicare beneficiaries may be able to get a GLP-1 prescription for weight loss for $50 a month. It’s a ...

In clinical trials, the drug was shown to almost double the survival time for pancreatic cancer patients. Here's how it works and who can get it.

In a clinical trial, the new weight-loss medication retatrutide led to "clinically meaningful weight reduction," with the ...

Researchers from the University of Houston and University of Michigan in Ann Arbor have developed a dual-target drug designed to overcome immunotherapy resistance in pancreatic cancer. The research ...

Having one stroke is scary and life-threatening enough. But according to the Centers for Disease Control and Prevention, ...

The father of a boy with a muscle-wasting disease has said he is "incredibly happy" that his son will now get access to a new ...